Racial/ethnic differences in medication for addiction treatment for opioid use disorders among pregnant women in treatment facilities supported by state funds

Medication for addiction treatment (MAT) for opioid use disorder (OUD) in pregnant women is known to improve neonatal health outcomes. Despite the benefits of this evidence-based treatment for OUD, MAT has been underutilized during pregnancy among certain racial/ethnic groups of women in the United States. The purpose of this study was to examine racial/ethnic differences and factors that affect MAT administration among pregnant women with OUD seeking treatment at publicly funded facilities.

Source: Journal of Substance Abuse Treatment - January 25, 2023 Category: Addiction Authors: Panagiota Kitsantas, Salman M. Aljoudi, Kelley M. Baker, Lora Peppard, Kyeung Mi Oh Source Type: research